Literature DB >> 9774369

Calcium channel blockade enhances nitric oxide synthase expression by cultured endothelial cells.

Y Ding1, N D Vaziri.   

Abstract

In a recent study, we found marked increases in nitric oxide (NO) production and endothelial and inducible NO synthase (eNOS and iNOS) expressions with calcium channel blockade in rats with chronic renal failure. This study was undertaken to determine whether enhanced NO production with calcium channel blockade is a direct effect of this therapy or a consequence of the associated hemodynamic and humoral changes. We tested the effects of a calcium channel blocker, felodipine (10(-5), 10(-6), and 10(-7) mol/L), on nitrate and nitrite (NOx) generation, Ca2+-dependent and -independent NOS activity, and eNOS and iNOS protein masses in proliferating and quiescent rat aortic endothelial cells in culture. Compared with vehicle alone, felodipine significantly increased NOx generation, Ca2+-dependent NOS activity, and eNOS protein mass in proliferating and quiescent endothelial cells. Felodipine did not modify the stimulatory action of 10% fetal calf serum on DNA synthesis (thymidine incorporation) and cell proliferation. Ca2+-independent NOS activity and iNOS protein expression were negligible and unaffected by calcium channel blockade. NOx production and NOS expression were greater in proliferating cells than in quiescent cells. Thus, calcium channel blockade upregulates endothelial NO production in vitro, confirming our previous in vivo study. This observation indicates that the reductions in cytosolic [Ca2+] and vasodilation with calcium channel blockade are not only due to inhibition of Ca2+ entry but also to an NO-cGMP mediated mechanism.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9774369     DOI: 10.1161/01.hyp.32.4.718

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  13 in total

1.  Effects of amlodipine and lacidipine on cardiac remodelling and renin production in salt-loaded stroke-prone hypertensive rats.

Authors:  J Kyselovic; P Krenek; M Wibo; T Godfraind
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

2.  Insights into the effect of nitric oxide and its metabolites nitrite and nitrate at inhibiting neointimal hyperplasia.

Authors:  Ashley K Vavra; George E Havelka; Janet Martinez; Vanessa R Lee; Bo Fu; Qun Jiang; Larry K Keefer; Melina R Kibbe
Journal:  Nitric Oxide       Date:  2011-04-30       Impact factor: 4.427

Review 3.  Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke.

Authors:  Kirtiman Srivastava; Philip M W Bath; Ulvi Bayraktutan
Journal:  Cell Mol Neurobiol       Date:  2011-12-25       Impact factor: 5.046

4.  AVE3085, an enhancer of endothelial nitric oxide synthase, restores endothelial function and reduces blood pressure in spontaneously hypertensive rats.

Authors:  Qin Yang; Hong-Mei Xue; Wing-Tak Wong; Xiao-Yu Tian; Yu Huang; Stephen K W Tsui; Patrick Ks Ng; Paulus Wohlfart; Huige Li; Ning Xia; Silke Tobias; Malcolm John Underwood; Guo-Wei He
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

5.  Felodipine reduces cardiac expression of IL-18 and perivascular fibrosis in fructose-fed rats.

Authors:  Shan-Shan Xing; Hong-Wei Tan; Xiu-Ping Bi; Ming Zhong; Yun Zhang; Wei Zhang
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

6.  Antihypertensive medications and diastolic dysfunction progression in an African American population.

Authors:  Heather M Prendergast; Samuel Dudley; Michael Brown; Martha Daviglus; John Kane; E Bradshaw Bunney; Jared Marcucci; Rasheed Sanyaolu
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-06-28

7.  Icariin intervenes in cardiac inflammaging through upregulation of SIRT6 enzyme activity and inhibition of the NF-kappa B pathway.

Authors:  Yang Chen; Tao Sun; Junzhen Wu; Bill Kalionis; Changcheng Zhang; Ding Yuan; Jianhua Huang; Waijiao Cai; Hong Fang; Shijin Xia
Journal:  Biomed Res Int       Date:  2015-01-20       Impact factor: 3.411

8.  "Non alcoholic fatty liver disease and eNOS dysfunction in humans".

Authors:  Marcello Persico; Mario Masarone; Antonio Damato; Mariateresa Ambrosio; Alessandro Federico; Valerio Rosato; Tommaso Bucci; Albino Carrizzo; Carmine Vecchione
Journal:  BMC Gastroenterol       Date:  2017-03-07       Impact factor: 3.067

9.  TRIB3 rs6037475 is a potential biomarker for predicting felodipine drug response in Chinese patients with hypertension.

Authors:  Fazhong He; Bao Sun; Ling Li; Mouze Liu; Weijie Lin; Lin Liu; Yinxiang Sun; Yuhong Luo; Lin Wu; Ligong Lu; Wei Zhang; Zhiling Zhou
Journal:  Ann Transl Med       Date:  2020-04

10.  The Antihypertensive Drug Nifedipine Modulates the Metabolism of Chondrocytes and Human Bone Marrow-Derived Mesenchymal Stem Cells.

Authors:  Ilona Uzieliene; Eiva Bernotiene; Greta Rakauskiene; Jaroslav Denkovskij; Edvardas Bagdonas; Zygmunt Mackiewicz; Narunas Porvaneckas; Giedrius Kvederas; Ali Mobasheri
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-08       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.